Atorvastatin causes regression of endometriotic implants in a rat model

Bülent Yılmaz, Bulent Yilmaz, Mustafa Özat, Mustafa Ozat, Sevtap Kilic, Sevtap Kılıç, Tayfun Gungor, Yasemin Aksoy, Nese Lordlar, Necdet Süt, Necdet Sut, Orhan Aksakal
Reproductive biomedicine online · 2009 · vol. 20(2) , pp. 291–299 · doi:10.1016/j.rbmo.2009.11.004 · PMID:20113969 · W2040325288
article OA: bronze CC0 ⤵ 39 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

In a rat model, atorvastatin treatment effectively reduced the size and number of surgically induced endometriotic implants.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715

MeSH descriptors

Antioxidants Endometriosis Heptanoic Acids Pyrroles Animals Antioxidants Antioxidants Atorvastatin Disease Models, Animal Endometriosis Endometriosis Endometrium Endometrium Endometrium Female Heptanoic Acids Heptanoic Acids Pyrroles Pyrroles Rats

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (57)

Cited by (39)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:17:18.915199+00:00
License: CC0 · commercial use OK